Abstract
DNA ploidy and cell-cycle distribution were determined by flow cytometry in fresh tumour tissue of 53 cervical carcinomas. Epithelial cells were labelled by a fluorescein-isothiocyanate-conjugated cytokeratin antibody (CK6, CK18) to study the influence of contaminating stromal and inflammatory cells on results of cell-cycle analysis of tumour cells. Without identification of cytokeratin-positive cells 30/53 (57%) tumours were found to be DNA-aneuploid compared to 43/53 (81%) after gating for cytokeratin. Only 7 of 15 DNA-multiploid tumours could be detected without cytokeratin staining. In addition, cytokeratin-negative cells, which are found in all tumours, can be used as an internal standard for the calculation of ploidy and for quality control (coefficient of variation, linearity) of each individual sample. Cell-cycle analysis revealed significantly higher S-phase and G2M-phase fractions in cytokeratin-gated compared to ungated samples (13.1% versus 10.0% and 8.0% versus 5.4%;P<0.001). This difference was more pronounced in DNA-diploid than DNA-aneuploid tumours. In conclusion, about 30% of DNA-aneuploid tumours could only be detected after cytokeratin labelling of epithelial cells. Owing to the identification of cytokeratin-positive cells the influence of non-tumoural cell elements on cell-cycle analysis was reduced markedly. Therefore, in cervical cancer, cytokeratin labelling can optimize both the determination of DNA ploidy and cell-cycle analysis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Askensten UG, Rosen AK von, Nilsson RS, Auer GU (1988) Intratumoural variations in DNA distribution patterns in mammary adenocarcinomas. Cytometry 10: 326–333
Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D (1992) Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 13: 577–585
Bijman JT, Wagener DJT, Wessels JMC, Broek P van den, Raemakers FCS (1986) Cell size, DNA, and cytokeratin analysis of human head and neck tumours by flow cytometry. Cytometry 7: 76–81
Connor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR (1993) Flow cytometric evaluation of early invasive cervical cancer. Obstet Gynecol 81(3): 367–371
Dam PA van, Watson JV, Lowe DG, Shepherd JH (1992) Flow cytometric DNA analysis in gynecological oncology. Int J Gycecol Cancer 2: 57–62
Dawson AE, Norton JA, Weinberg DS (1990) Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry: Am J Pathol 136: 1115–1124
Dean PN (1986) Data analysis and cell kinetics research. In: Gray JW, Darzynkiewicz Z (eds), Techniques in cell-cycle analysis. Humana, Clifton, NJ, pp 207–253
Falkmer UG, Hagmar T, Auer G (1990) Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: a methodological study based on a routine histopathological material of 2024 excised, tumour specimens. Anal Cell Pathol 2: 297–312
Ferrero M, Spyratos F, Le Doussal V, Desplaces A, Rouesse J (1990) Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumours. Cytometry 11: 716–724
Hiddemann W, Schuhmann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA (1984) Convention on nomenclature for DNA cytometry. Cytometry 5: 445–446
Jakobsen A, Bichel P, Vaeth M (1985) New prognostic factors in squamous cell, carcinoma of cervix uteri. Am J Clin Oncol 8: 39–43
Kedar E, Ikejiri BL, Bonnard GD, Herbermann RB (1982) A rapid technique for isolation of viable tumour cells for solid tumours: use of the tumour cells for induction and measurement of cell-mediated cytotoxic responses. Eur J Cancer Clin Oncol 18: 991–1000
Kenter GG, Cornelisse CJ, Aartsen EJ, Mody W, Hermans J, Heintz APM, Fleurern GJ (1990) DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix. Gynecol Oncol 39: 181–185
Leminen A, Paavonen J, Vesterinen E, Forss M, Wahlströhm T, Kulomaa P, Lehtinen M (1990) Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of DNA-ploidy and S-phase fraction. Am J Obstet Gynecol 162: 848–853
Linden JC van der, Herman CJ, Boenders JGC, Sandt MM van de, Lindeman J (1992) Flow cytometric DNA content of fresh tumour specimens using keratin-antibody as second stain for two parameter analysis. Cytometry 13: 163–168
Moll R, Franke WW, Schiller DL, Geiger G, Krepler R (1982) The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumours and cultured cells. Cell 31: 11–24
Nguyen HN, Sevin BU, Averette HE, Ganjei P, Perras J, Ramos R, Angioli R, Donato D, Penalver M (1993), The role of DNA index as a prognostic factor in early cervical carcinoma. Gynecol Oncol 50: 54–59
Oud PS, Henderik JBJ, Beck HLM, Veldhuizen JAM, Vooijs GP, Herman CJ, Raemaekers FCS (1985) Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labelling for cytokeratin using a monoclonal antibody. Cytometry 6: 159–164
Ramackers F, Huysmans A, Moesker O, Kant A, Jap P, Herman C, Vooijs P (1983) Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumours. Use in surgical pathology. Lab Invest 49: 353–361
Raemaekers FCS, Beck JLM, Feitz WFJ, Oud PS, Debruyne FMJ, Vooijs GP and Herman, CJ (1986) Application of antibodies to intermediate filament proteins as tissue specific probes in the flowcytometric analysis of complex tumours. Anal Quant Cytol Histol 8: 271–280
Snedecor GW, Cochran WG (1973) Statistical methods, 6th.edn. Iowa State University Press Ames, Iowa, pp 327–329
Strang P, Eklund G, Stendahl U, Frankedal B, Lindgren B (1987) S-phase rate as a predictor of early recurrences ín carcinoma of the uterine cervix. Anticancer Res 7: 807–810
Strang P, Stendahl U, Bergström R, Frankendal B, Tribukait B (1991) Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients. Gynecol Oncol 43: 3–8
Visscher DW, Zarbo RJ, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman JD (1990) Multiparametric deoxyribonucleic acid and cellcycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. Lab Invest 62: 370–378
Zanetta GM, Katzmann JA, Keeney GL, Kinney WK, Cha SS, Podratz KC (1992) Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol Oncol 46: 13–19
Zarbo RJ, Visscher DW, Crissman JD (1989) Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 11: 391–402
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimmig, R., Kapsner, T., Spelsberg, H. et al. DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells. J Cancer Res Clin Oncol 121, 107–114 (1995). https://doi.org/10.1007/BF01202222
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01202222